<DOC>
	<DOCNO>NCT01099917</DOCNO>
	<brief_summary>Researchers Memorial Sloan-Kettering Cancer Center , collaboration The New York Presbyterian Hospital-Weill Medical College Cornell University , conduct study medicinal mushroom extract call Maitake ( pronounced my-tock-e ) . Laboratory study show Maitake reduce growth cancer animal . The Maitake kill cancer cell directly . It believe work immune system ( body 's defense system infection ) . Our test tube , animal human dose determine study show Maitake enhance immune function . We conduct study see whether Maitake improve neutrophil count function patient MDS . The neutrophils white blood cell help fight infection .</brief_summary>
	<brief_title>Does Maitake Mushroom Extract Enhance Hematopoiesis Myelodysplastic Patients ?</brief_title>
	<detailed_description />
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>MSKCC patient age 18 old able sign inform consent Absolute Neutrophil count &gt; 0.5 K/mcL Diagnosis MDS bone marrow biopsy Patient candidate aggressive standard treatment IPSS ( High risk ) History AML History Stem Cell transplant Known history HIV+ Allergy mushroom Bone Marrow blast &gt; 10 % HEALTHY CONTROL ELIGIBILTY CRITERIA Inclusion Criteria Age â‰¥55 year Exclusion Criteria Currently take corticosteroid immunosuppressant Known history HIV+ Current previous malignancy hematology disorder except adequately treat nonmelanoma skin cancer , curatively treated insitu cancer cervix , solid tumor curatively treat evidence disease &gt; 3 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>MDS</keyword>
	<keyword>Maitake</keyword>
	<keyword>mushroom</keyword>
	<keyword>09-094</keyword>
</DOC>